Treating ovarian cancers with PARP inhibitors

Evaluation of M7824, a bifunctional fusion protein targeting TGF-β and PD-L1, in patients with HPV-associated malignancies

Using T cell engineering plus triple checkpoint blockade to enhance the efficacy of adoptive immunotherapy in ovarian cancer

Combining the SLP vaccine with chemo-immunotherapy in order to increase the HPV-specific T-cell response in cervical cancer

Gynaecological cancer: Where are we now?

Innovating India: Rural healthcare in Salboni

BGICC 2019

Where does neoadjuvant chemotherapy in advanced ovarian cancer fit in clinical practice?

New FIGO staging in vulval and cervical cancer

Can we cure cervical cancer?

Fertility issues during adjuvant treatment in premenopausal breast cancer patients

Pushing for cost effective interventions in lower and middle income countries